Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Should Investors Trust Pfizer?

Published 04/02/2015, 06:09 AM
Updated 07/09/2023, 06:31 AM

It has been more than a year since we last wrote about Pfizer Inc (NYSE:PFE). On March 28th 2014, the stock was trading around 32.40, but the Elliott Wave Principle was warning us about a probable reversal to the downside. The chart below shows how things looked like, when we published “Pfizer Inc. At The End Of The Road”.
Pfizer Daily Chart
Our bearish outlook was supported by two consecutive patterns. A triangle in the position of wave (4) and an ending diagonal for wave (5). So, despite Pfizer’s multi-year advance, we decided to stick to the wave analysis. Was this the right thing to do? Find the answer on the next chart.
Pfizer Daily Chart II
Yes, it was. The price of Pfizer’s shares fell from 32.66 to 27.50 in less than seven months. In October 2014, the bears got tired and the rally resumed. Last week, Pfizer Inc. stock reached 35.40. But is it going to get even more expensive? Is this the right time to invest in Pfizer? In our opinion, the answer to both questions is “no”. The following chart explains why.
Pfizer Weekly
As visible, Pfizer has drawn a nicely-looking five-wave impulse to the upside, starting from the bottom in 2009. According to the theory, every impulse is followed by a three-wave correction in the opposite direction. This means we should expect a significant decline, once wave V is over. If this is the correct count, now could be the worst possible moment for an investment in Pfizer stock.

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.